This federal contract award, issued by the Defense Logistics Agency (DLA), is for a prime vendor pharmaceutical contract with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,162.52 delivery order is a firm fixed-price contract for the provision of a wide range of pharmaceutical products, medical supplies, and healthcare commodities to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions.
The contract, which runs through April 2021, is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical and medical products, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to DLA facilities worldwide. The contract is not designated with any set-aside requirements, indicating open competition. Additionally, Amerisourcebergen Drug Corp maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.
Generated 2/27/25, 9:51 AM